Karen Akinsanya
Vermogen: - $ op 31-08-2026
Vermogen: - $ op 31-08-2026
Dr. Karen Akinsanya is an Independent Director at Nautilus Biotechnology, Inc., a Chief Strategy Officer & President-Partnerships at Schrödinger, Inc. and a President at Envision Science Group LLC.
She is on the Board of Directors at Nautilus Biotechnology, Inc. and The Rockefeller University.
Dr. Akinsanya was previously employed as an Associate Vice President by Merck & Co., Inc. She received her undergraduate degree from Queen Mary University of London and a doctorate degree from Imperial College London.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-06-2026 | 0 ( -.--% ) | - $ | 31-08-2026 | |
SCHRODINGER, INC. -.--% | 17-09-2026 | 0 ( -.--% ) | - $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| SCHRÖDINGER, INC. | Hoofd Techniek/Wetenschap/O&O | 01-04-2022 |
| NAUTILUS BIOTECHNOLOGY, INC. | Directeur/Bestuurslid | 30-03-2022 |
Envision Science Group LLC | Oprichter | 01-01-2007 |
The Rockefeller University
The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01-07-2017 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 7 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Rockefeller University
The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Schrödinger, Inc.
Schrödinger, Inc. Packaged SoftwareTechnology Services Develops physics-based software platform which enables discovery of novel molecules for drug development and materials applications | Technology Services |
Queen Mary University of London
Queen Mary University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nautilus Biotechnology, Inc.
Nautilus Biotechnology, Inc. BiotechnologyHealth Technology Develops proteomics platform for analyzing and quantifying the human proteome | Health Technology |
Envision Science Group LLC |
Kies jouw editie
Alle financiële informatie op nationaal niveau